ATC code H01

ATC codes
H Systemic hormonal preparations, excluding sex hormones and insulins
	H01 Pituitary and hypothalamic hormones and analogues
	H02 Corticosteroids for systemic use
	H03 Thyroid therapy
	H04 Pancreatic hormones
	H05 Calcium homeostasis
	A; B; C; D; G; H; QI; J; L; M; N; P; R; S; V;
	A; B; C; D; G; H; QI; J; L; M; N; P; R; S; V;

ATC code H01 Pituitary and hypothalamic hormones and analogues is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup H01 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH01.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

H01A Anterior pituitary lobe hormones and analogues

H01AA Adrenocorticotropic hormone

H01AA01 Corticotropin

H01AA02 Tetracosactide

H01B Posterior pituitary lobe hormones

H01BA Vasopressin and analogues

H01BA01 Vasopressin (argipressin)

H01BA02 Desmopressin

H01BA03 Lypressin

H01BA04 Terlipressin

H01BA05 Ornipressin

H01BB Oxytocin and analogues

H01BB01 Demoxytocin

H01BB02 Oxytocin

H01BB03 Carbetocin

H01C Hypothalamic hormones

H01CA Gonadotropin-releasing hormones

H01CA01 Gonadorelin

H01CA02 Nafarelin

QH01CA90 Buserelin

QH01CA91 Fertirelin

QH01CA92 Lecirelin

QH01CA93 Deslorelin

QH01CA94 Azagly-nafarelin

QH01CA95 Peforelin

QH01CA96 Salmon gonadotropin releasing hormone analogue

QH01CA97 Triptorelin

QH01CA98 Alarelin

H01CB Somatostatin and analogues

H01CB01 Somatostatin

H01CB02 Octreotide

H01CB03 Lanreotide

H01CB04 Vapreotide

H01CB05 Pasireotide

H01CC Anti-gonadotropin-releasing hormones

H01CC01 Ganirelix

H01CC02 Cetrorelix

H01CC03 Elagolix

H01CC04 Linzagolix

H01CC54 Relugolix, estradiol and norethisterone

References

"ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
"Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
"ATC/DDD Index 2022: code H01". WHO Collaborating Centre for Drug Statistics Methodology.
"ATCvet Index 2022: code QH01". WHO Collaborating Centre for Drug Statistics Methodology.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.

[2] World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.

[3] "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.

[4] "ATC/DDD Index 2022: code H01". WHO Collaborating Centre for Drug Statistics Methodology.

[5] "ATCvet Index 2022: code QH01". WHO Collaborating Centre for Drug Statistics Methodology.